Investor Relations

Press Release

March 12, 2020

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2019

More
March 5, 2020

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12th, 2020

More
February 27, 2020

Amphastar Pharmaceuticals Receives FDA Approval for Supplement to its Abbreviated New Drug Application for Sodium Bicarbonate Injection, USP 8.4%, 50mEq/50mL

More
January 28, 2020

Amphastar Announces the Receipt of a MINOR CRL for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial

More
November 27, 2019

Amphastar Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference

More
November 15, 2019

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

More
November 7, 2019

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2019

More
November 1, 2019

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7th, 2019

More
August 29, 2019

Amphastar Pharmaceuticals to Present at the Wells Fargo 2019 Healthcare Conference

More
August 7, 2019

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2019

More